北大医药：全资子公司与北京大学国际医院业务合作将终止 预计减少收入6亿元

Core Viewpoint - The company, Peking University Pharmaceutical (000788.SZ), announced the termination of its long-term service contract with Peking University International Hospital, which is expected to lead to a significant reduction in revenue and net profit starting from June 2025 [1] Financial Impact - The termination of the business cooperation is projected to result in a revenue decrease of approximately 600 million yuan (6 billion) from June 2025 to the end of 2025 [1] - The net profit is expected to decline by around 40 million yuan (4 million) due to this contract termination [1] Strategic Response - The company plans to actively collect accounts receivable from the international hospital and is committed to improving operational performance to offset the anticipated loss in revenue and profit [1]